Suppr超能文献

溶液性质对通过光阻法和数字成像法测量的亚可见颗粒标准品计数和粒径测定的影响。

Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods.

作者信息

Werk Tobias, Volkin David B, Mahler Hanns-Christian

机构信息

Pharmaceutical Development & Supplies, Pharma Technical Development Biologics EU, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

Department of Pharmaceutical Chemistry, Macromolecule and Vaccine Stabilization Center, University of Kansas, Lawrence, Kansas 66047, USA.

出版信息

Eur J Pharm Sci. 2014 Mar 12;53:95-108. doi: 10.1016/j.ejps.2013.12.014. Epub 2013 Dec 23.

Abstract

PURPOSE

Protein formulations may contain subvisible particle (SbVP) impurities that can vary (e.g., in number, size, shape, density, refractive index and transparency) depending on the formulation composition, environmental stresses and the type of protein. Additionally formulation solutions may differ in their physical properties including turbidity, color, viscosity, density and refractive index. This study examined the impact of these formulation matrix parameters on the ability to size and count subvisible particles using a variety of analytical methods including two light obscuration (HIAC, Syringe) and two digital imaging instruments (MFI®, FlowCAM®). Several subvisible particle standards were tested, including polystyrene and glass beads as well as a new pseudo-protein particle standard, in order to also study of the effect of subvisible particles with different properties.

RESULTS

The color and turbidity of solutions generally had a relatively small effect on SbVP sizing and counting. Solution viscosity and refractive index (RI), however, showed a more pronounced effect on the analytical results, especially with more translucent particles such as glass beads and the "pseudo protein standards", resulting in smaller sizes and lower counts of SbVPs, especially when measuring particles using light obscuration methods.

CONCLUSIONS

Each instrument showed certain advantages and disadvantages depending on the analytical parameter (i.e., accuracy, precision), type of subvisible particle, and solution properties. Based on these results, it is recommended to not only carefully consider physical solution parameters as part of analytical method assessment for counting and sizing SbVP in protein dosage forms, but also in terms of various typical QC validation parameters using actual protein formulations.

摘要

目的

蛋白质制剂可能含有亚可见颗粒(SbVP)杂质,其数量、大小、形状、密度、折射率和透明度等可能因制剂组成、环境压力和蛋白质类型而异。此外,制剂溶液的物理性质也可能不同,包括浊度、颜色、粘度、密度和折射率。本研究使用多种分析方法,包括两种光阻法(HIAC、注射器法)和两种数字成像仪器(MFI®、FlowCAM®),考察了这些制剂基质参数对亚可见颗粒大小测定和计数能力的影响。测试了几种亚可见颗粒标准品,包括聚苯乙烯和玻璃珠以及一种新型假蛋白颗粒标准品,以研究不同性质亚可见颗粒的影响。

结果

溶液的颜色和浊度通常对SbVP的大小测定和计数影响相对较小。然而,溶液粘度和折射率对分析结果的影响更为显著,尤其是对于玻璃珠和“假蛋白标准品”等半透明颗粒,会导致SbVP的尺寸变小和计数降低,特别是在使用光阻法测量颗粒时。

结论

根据分析参数(即准确性、精密度)、亚可见颗粒类型和溶液性质,每种仪器都有一定的优缺点。基于这些结果,建议在评估蛋白质剂型中SbVP计数和大小测定的分析方法时,不仅要仔细考虑溶液的物理参数,还要考虑使用实际蛋白质制剂的各种典型质量控制验证参数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验